
aXichem Investor Relations Material
Latest events

Q1 2025
aXichem

Q1 2025
22 May, 2025

Q4 2024
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from aXichem
Access all reports
aXichem AB is a Swedish biotechnology company focused on developing natural analogue ingredients. Its flagship product, phenylcapsaicin, is a synthetic version of capsaicin used in various industries, including animal feed, dietary supplements, and marine applications. The company's solutions include aXivite, which is used in health supplements to support weight management and gut health, and aXiphen, a bio-repellent applied in agriculture, marine antifouling, and animal feed to promote health and prevent issues like salmonella in poultry. The company is headquartered in Malmö, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AXIC
Country
🇸🇪 Sweden